by Jordana Choucair | Aug 8, 2022 | Opioid/Substance Use Disorders
The Washington Post will host an event with Representatives Brian Fitzpatrick and Ann McLane Kuster – co-chairs of the Bipartisan Addiction and Mental Health Task Force – about their mental health legislation. The legislation is focused on easing access to mental...
by Jordana Choucair | Aug 5, 2022 | Opioid/Substance Use Disorders
Tennessee Attorney General Herbert Slatery III filed a lawsuit accusing Walgreens of creating a public nuisance by illegally selling and distributing opioids. According to Slatery, Walgreens dispensed more than 1.1 billion opioid prescriptions to the state’s 7...
by Jordana Choucair | Aug 2, 2022 | Opioid/Substance Use Disorders
West Virginia reached a $400 million tentative settlement with three drug distributors. The state’s cities and counties sued AmerisourceBergen, Cardinal Health, and McKesson for their role in fueling the opioid epidemic. If the individual cities and counties approve...
by Jordana Choucair | Jul 28, 2022 | Opioid/Substance Use Disorders
Allergan, a subsidiary of AbbVie, agreed to a $2 billion settlement with state and local governments to end thousands of lawsuits related to the marketing of its opioid Kadian. A federal court in Cleveland is working out details, such as the payout period and what...
by Jordana Choucair | Jul 27, 2022 | Opioid/Substance Use Disorders
Teva Pharmaceuticals reached a tentative $4.25 billion settlement with states and localities over its role in the opioid addiction crisis. The deal requires Teva to make payments to approximately 2,500 local governments, states, and tribes over the course of 13 years....
by Jordana Choucair | Jul 20, 2022 | Opioid/Substance Use Disorders
The Centers for Disease Control and Prevention (CDC) released new data indicating that overdose death rates surged among Black, American Indian, and Alaska Native individuals in 2020. According to the data from 25 states and the District of Columbia, the overdose...
Recent Comments